Latest news and press releases about ENDRA Life Sciences Inc. (NDRA): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood.
Price
| Price | $5.30 |
| Market Cap | $7M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.11 |
| EV / EBITDA | -0.48 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -310.93% |
| Return on Invested Capital | -178.30% |
| Return on Assets | -182.35% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: BBLG · BGMS · BNBX · DHAI · GCTK · HSCS · ISPC
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of NDRA: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks